Tomasz Szul
Overview
Explore the profile of Tomasz Szul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
958
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meissner J, Akhmetova K, Szul T, Viktorova E, Sha B, Bhatt J, et al.
Front Cell Dev Biol
. 2023 Sep;
11:1233272.
PMID: 37745300
Golgi homeostasis require the activation of Arf GTPases by the guanine-nucleotide exchange factor requires GBF1, whose recruitment to the Golgi represents a rate limiting step in the process. GBF1 contains...
2.
Sager G, Szul T, Lee E, Kawai R, Presley J, Sztul E
Mol Biol Cell
. 2021 Jan;
32(5):446-459.
PMID: 33405949
The components and subprocesses underlying the formation of COPI-coated vesicles at the Golgi are well understood. The coating cascade is initiated after the small GTPase Arf1 is activated by the...
3.
Moghimi S, Viktorova E, Zimina A, Szul T, Sztul E, Belov G
J Virol
. 2020 Oct;
95(2).
PMID: 33087467
Enterovirus replication requires the cellular protein GBF1, a guanine nucleotide exchange factor for small Arf GTPases. When activated, Arfs associate with membranes, where they regulate numerous steps of membrane homeostasis....
4.
Betella I, Turbitt W, Szul T, BinghaoWu , Martinez A, Katre A, et al.
Gynecol Oncol
. 2020 Aug;
159(1):295.
PMID: 32839025
No abstract available.
5.
Betella I, Turbitt W, Szul T, Wu B, Martinez A, Katre A, et al.
Gynecol Oncol
. 2020 Mar;
157(3):765-774.
PMID: 32192732
Objectives: Wnt pathway mutations are a hallmark of endometrioid and clear cell subtypes of epithelial ovarian carcinoma (EOC). However, no drugs targeting the Wnt pathway in EOC are FDA-approved. Dickkopf-related...
6.
Arend R, Martinez A, Szul T, Birrer M
Cancer
. 2020 Jan;
125 Suppl 24:4563-4572.
PMID: 31967683
Biomarkers are becoming increasingly important in the treatment of epithelial ovarian cancer. Recent work from many laboratories has begun to provide clinically meaningful biomarkers. This review summarizes the state of...
7.
Roda M, Xu X, Abdalla T, Sadik M, Szul T, Bratcher P, et al.
Am J Respir Cell Mol Biol
. 2019 Apr;
61(5):560-566.
PMID: 30958968
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide and is characterized by an excessive airway neutrophilic response. The neutrophil chemoattractant proline-glycine-proline (PGP) and its more potent...
8.
Genschmer K, Russell D, Lal C, Szul T, Bratcher P, Noerager B, et al.
Cell
. 2019 Jan;
176(1-2):113-126.e15.
PMID: 30633902
Here, we describe a novel pathogenic entity, the activated PMN (polymorphonuclear leukocyte, i.e., neutrophil)-derived exosome. These CD63/CD66b nanovesicles acquire surface-bound neutrophil elastase (NE) during PMN degranulation, NE being oriented in...
9.
Lal C, Olave N, Travers C, Rezonzew G, Dolma K, Simpson A, et al.
JCI Insight
. 2018 Mar;
3(5).
PMID: 29515035
Premature infants are at high risk for developing bronchopulmonary dysplasia (BPD), characterized by chronic inflammation and inhibition of lung development, which we have recently identified as being modulated by microRNAs...
10.
Lutful Kabir F, Ambalavanan N, Liu G, Li P, Solomon G, Lal C, et al.
Am J Respir Crit Care Med
. 2017 Dec;
197(5):632-643.
PMID: 29232160
Rationale: MicroRNAs (miRNAs) destabilize mRNA transcripts and inhibit protein translation. miR-145 is of particular interest in cystic fibrosis (CF) as it has a direct binding site in the 3'-untranslated region...